Arca

Pharma markets this week

Sep 21 to Sep 27, 2026

6 funding rounds, 3 PDUFA dates, 5 officer changes.

Funding rounds of $5 million or more, and IPOs 6

Funding rounds

PDUFA dates companies have disclosed 3

PDUFA calendar

Praxis Precision Medicines, Inc.

FDA goal date for relutrigine (NDA), for SCN2A and SCN8A developmental and epileptic encephalopathies

2026-09-27 · Disclosed by Praxis Precision Medicines, Inc.

Source

Mirum Pharmaceuticals, Inc.

FDA goal date for zilurgisertib (NDA), for fibrodysplasia ossificans progressiva

2026-09-26 · Disclosed by Mirum Pharmaceuticals, Inc.

Source

Officer and director changes 5

Beyond Air, Inc.

Change in directors or officers

2026-09-24 · Form 8-K, Item 5.02. The filing does not say who joined or left.

Source

Valion Bio, Inc.

Change in directors or officers

2026-09-23 · Form 8-K, Item 5.02. The filing does not say who joined or left.

Source